Cipla gets USFDA nod for inhalation product
NEW DELHI: Drug major Cipla on Wednesday said it has received final approval from the US health regulator for Arformoterol Tartrate Inhalation Solution, used to treat conditions like chronic bronchitis and emphysema, in the US market. The approved product is a generic version of Sunovion Pharmaceuticals Inc’s Brovana. The company has received final approval for […]
Remdesivir prices cut on government intervention: Industry Body
NEW DELHI: To enhance the availability of remdesivir injection, used in the treatment of COVID-19, pharmaceutical companies have reduced the price following the government’s intervention, the National Pharmaceutical Pricing Authority (NPPA) said on Saturday. Drug companies like Cadila Healthcare, Dr Reddy’s Laboratories and Cipla have cut the prices of their respective brands of remdesivir injection […]
Cipla board approves reappointment of Umang Vohra as MD & Global CEO
NEW DELHI: Pharma major Cipla on Tuesday said its board hasapproved the re-appointment of Umang Vohra as the Managing Director and Global CEO of the company for a further period of five years. The board of directorshas considered and approved the re-appointment ofUmang Vohra, Managing Director, designated as ‘Managing Director and Global Chief ExecutiveOfficer’ of […]
Cipla to launch cinacalcet hydrochloride tablets in USA
NEW DELHI: Drug major Cipla and its subsidiary Cipla USA on Wednesday announced a phased launch of generic cinacalcet hydrochloride tablets, used in the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease on dialysis, in the US market. The launch, however, is a subject of ongoing litigation, Cipla said in a […]